// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
That would mean no cakes or ice cream for children until their second birthday, and fewer than six teaspoons per day of added sugar.
“Due to a recent economic upturn, the streets are filled with restaurants and cafes that are perfect for working remotely,” the magazine says.
Among Armenia's strengths are mentioned ease of starting a business, innovation efficiency ratio, females employed with advanced degrees.
Armenian court ruled to use arrest as a preventive measure against Vladimir M. and Seyran K.
Partner news